Brief: VIVA Biotech Announces Reset Of Conversion Price Of 2.50% Guaranteed Convertible Bonds Due 2025
Feb 17 (Reuters) - VIVA Biotech Holdings 1873.HK :
* RESET OF CONVERSION PRICE OF 2.50% GUARANTEED CONVERTIBLE
BONDS
DUE 2025
* NOTIFIED BONDHOLDERS THAT CONVERSION PRICE IS RESET FROM
HK$5.7456 TO HK$5.11 PER SHARE
* AS AT FEB 17, AGGREGATE PRINCIPAL AMOUNT OF US$32 MILLION
OF
BONDS REMAIN OUTSTANDING
Further company coverage: 1873.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on VIVA Biotech Holdings
See all newsVIVA Biotech H1 profit falls on weaker investment income, FX headwinds
Brief: Viva Biotech Posts FY Net Profit RMB269.3 Million
Brief: Viva Biotech Received Declaration Letter
Brief: Viva Biotech Says Hangzhou Viva Zongchen Agreed To Invest RMB25.0 Million To Fund
Brief: Viva Biotech Passing Of U.S. FDA On-Site Inspection By Langhua Pharmaceutical